Timeline of Selected FDA Activities and Significant Events Addressing Opioid Misuse and Abuse
Similar Posts
MedWatch: The FDA Safety Information and Adverse Event Reporting Program
MedWatch is made up of voluntary and mandatory reporting on prescription medicines, over-the-counter medicines, non-vaccine biologicals, medical devices, special nutritional products, cosmetics and non-prescription human drug products marketed without an approved application.Transderm Scōp (Scopolamine Transdermal System): Drug Safety Communication – FDA Adds Warning About Serious Risk of Heat-Related Complications with Antinausea Patch
The FDA is warning that the antinausea patch Transderm Scōp (scopolamine transdermal system) can increase body temperature and cause heat-related complications, resulting in hospitalization or even death in some cases. Most cases occurred in children 17 years and younger and in adults 60 years and oAkorn Pharmaceuticals Inc. Decatur, IL. 483 Issued 06/10/2016
Akorn Pharmaceuticals Inc. Decatur, IL. 483 Issued 06/10/2016C3TI Demonstration Program Proposal Submission
Submitting content and format of the C3TI Demonstration Program ProposaleCTD Submission Standards for eCTD v4.0 and Regional M1
A listing of the Implementation Guides, Specifications, and Documentation that support the FDA implementation for eCTD v4.0Compounding Quality Center of Excellence | Engage with the Compounding Quality Center of Excellence
Engage with the Compounding Quality Center of Excellence